Companies: 49,246 Total Market Cap: 132591774254860.43

Galderma Group AG

SWX-GALD

Healthcare Drug Manufacturers - Specialty & Generic

Rank #744

Market Cap 28.55 B

Volume 81,662

Price 121.45

Change (%) 1.00%

Country or region

Switzerland

Galderma Group AG's latest marketcap:

28.55 B

As of 05/20/2025, Galderma Group AG's market capitalization has reached $28.55 B. According to our data, Galderma Group AG is the 744th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	28.55 B
Revenue (ttm)	4.82 B
Net Income (ttm)	250.71 M
Shares Out	237.41 M
EPS (ttm)	1.05
Forward PE	40.71
Ex-Dividend Date	04/25/2025
Earnings Date	07/24/2025

Market Cap Chart

Data Updated: 05/20/2025

Galderma Group AG's yearly market capitalization.

Galderma Group AG has seen its market value drop from ₣23.91 B to ₣23.84 B since 2024, representing a total decrease of 0.31% and an annual compound decline rate (CAGR) of 0.79%.

Date	Market Cap	Change (%)
05/20/2025	₣23.84 B	-0.95%
12/30/2024	₣23.91 B

Company Profile

About Galderma Group AG

Galderma Group AG is a global leader in dermatology, offering a science-driven portfolio of products and services across multiple segments of the dermatology market.

Core Business Segments

Injectable Aesthetics: Features flagship brands like Dysport/Azzalure, Alluzience, Restylane, and Sculptra.
Dermatological Skincare: Includes renowned brands such as Cetaphil and Alastin.
Therapeutic Dermatology: Covers treatments like Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl.

Founded in 1981, Galderma Group AG is headquartered in Zug, Switzerland.

Frequently Asked Questions

As of 05/20/2025, Galderma Group AG (including the parent company, if applicable) has an estimated market capitalization of $28.55 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Galderma Group AG global market capitalization ranking is approximately 744 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Switzerland
Founded	1981
IPO Date	n/a
Employees	6,545
CEO	Flemming Ornskov
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Address	Zählerweg 10 Zug, 6300 Switzerland
Website	https://www.galderma.com